Last reviewed · How we verify
Prednisone withdrawal
At a glance
| Generic name | Prednisone withdrawal |
|---|---|
| Sponsor | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Evaluate Adverse Events and Change in Disease Activity of Subcutaneous (SC) Epcoritamab in Combination With Oral and Intravenous Anti-Neoplastic Agents in Adult Participants With Non-Hodgkin Lymphoma (PHASE2)
- Tocilizumab in Cardiac Transplantation (PHASE2)
- Tocilizumab Discontinuation Versus Dose Reduction for Patients With Well-Controlled Giant Cell Arteritis (PHASE2)
- Taper Or Abrupt Steroid Stop: TOASSTtrial (PHASE4)
- Corticosteroid Therapy in Pulmonary Sequelae of Covid-19 (PHASE1)
- Hyperpolarized (HP) 13C Pyruvate Magnetic Resonance Imaging (MRI) for Response Monitoring to Neoadjuvant Abiraterone (PHASE2)
- A Randomized Controlled Study of the Efficacy and Safety of Lenalidomide in the Treatment of Active IgG4-related Disease (PHASE2, PHASE3)
- Comparison of Two Strategies of Glucocorticoid Withdrawal in Rheumatoid Arthritis Patients (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |